Literature DB >> 21533877

Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus.

M Widerström1, J Wiström, A Sjöstedt, T Monsen.   

Abstract

Coagulase-negative staphylococci (CoNS), originally described as ubiquitous commensals of the healthy human skin and mucosa, have emerged as important opportunistic pathogens primarily causing healthcare-associated infections in patients with indwelling medical devices. Recent studies, utilizing new molecular typing methods, particularly on Staphylococcus epidermidis, have increased our understanding of the mechanisms that contribute to the evolutionary success of these extremely versatile microorganisms. In the following mini-review, we summarize recent research in this area focusing on the molecular methods and epidemiology of S. epidermidis and S. saprophyticus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533877     DOI: 10.1007/s10096-011-1270-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  123 in total

1.  Use of outer surface protein repeat regions for improved genotyping of Staphylococcus epidermidis.

Authors:  Alastair B Monk; Gordon L Archer
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

2.  Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements.

Authors: 
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

3.  Staphylococcus cohnii septicaemia in a patient with colon cancer.

Authors:  Giancarlo Basaglia; Laura Moras; Alessandra Bearz; Simona Scalone; Paolo De Paoli
Journal:  J Med Microbiol       Date:  2003-01       Impact factor: 2.472

4.  Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates.

Authors:  Natalia Malachowa; Artur Sabat; Marek Gniadkowski; Jolanta Krzyszton-Russjan; Joanna Empel; Jacek Miedzobrodzki; Klaudia Kosowska-Shick; Peter C Appelbaum; Waleria Hryniewicz
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis.

Authors:  D S Kernodle; N L Barg; A B Kaiser
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

6.  Whole-genome sequencing of staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species.

Authors:  Fumihiko Takeuchi; Shinya Watanabe; Tadashi Baba; Harumi Yuzawa; Teruyo Ito; Yuh Morimoto; Makoto Kuroda; Longzhu Cui; Mikio Takahashi; Akiho Ankai; Shin-ichi Baba; Shigehiro Fukui; Jean C Lee; Keiichi Hiramatsu
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

7.  Comparison of molecular typing methods for characterization of Staphylococcus epidermidis: proposal for clone definition.

Authors:  M Miragaia; J A Carriço; J C Thomas; I Couto; M C Enright; H de Lencastre
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

Review 8.  Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children.

Authors:  Julia Prusseit; Matthias Simon; Christian von der Brelie; Axel Heep; Ernst Molitor; Sebastian Volz; Arne Simon
Journal:  Pediatr Neurosurg       Date:  2009-11-11       Impact factor: 1.162

9.  Mediastinitis after cardiac surgery: improvement of bacteriological diagnosis by use of multiple tissue samples and strain typing.

Authors:  Ann Tammelin; Anna Hambraeus; Elisabeth Ståhle
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Multiple-locus variable number tandem repeat analysis of Staphylococcus aureus: comparison with pulsed-field gel electrophoresis and spa-typing.

Authors:  Leo M Schouls; Emile C Spalburg; Martijn van Luit; Xander W Huijsdens; Gerlinde N Pluister; Marga G van Santen-Verheuvel; Han G J van der Heide; Hajo Grundmann; Max E O C Heck; Albert J de Neeling
Journal:  PLoS One       Date:  2009-04-03       Impact factor: 3.240

View more
  49 in total

1.  Multilocus Sequence Analysis of Clinical "Candidatus Neoehrlichia mikurensis" Strains from Europe.

Authors:  Anna Grankvist; Edward R B Moore; Liselott Svensson Stadler; Sona Pekova; Christian Bogdan; Walter Geißdörfer; Jenny Grip-Lindén; Kenny Brandström; Jan Marsal; Kristofer Andréasson; Catharina Lewerin; Christina Welinder-Olsson; Christine Wennerås
Journal:  J Clin Microbiol       Date:  2015-07-08       Impact factor: 5.948

2.  A multidrug-resistant Staphylococcus epidermidis clone (ST2) is an ongoing cause of hospital-acquired infection in a Western Australian hospital.

Authors:  Micael Widerström; Cheryll A McCullough; Geoffrey W Coombs; Tor Monsen; Keryn J Christiansen
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

3.  Evaluation of Oxacillin and Cefoxitin Disk Diffusion and Microbroth Dilution Methods for Detecting mecA-Mediated β-Lactam Resistance in Contemporary Staphylococcus epidermidis Isolates.

Authors:  Samia N Naccache; Katrina Callan; C A Burnham; Meghan A Wallace; Lars F Westblade; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

4.  Molecular Epidemiology of a Vancomycin-Intermediate Heteroresistant Staphylococcus epidermidis Outbreak in a Neonatal Intensive Care Unit.

Authors:  Jasmine Chong; Caroline Quach; Ana C Blanchard; Philippe Guillaume Poliquin; George R Golding; Céline Laferrière; Simon Lévesque
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Coagulase-negative staphylococci in outpatient routines: the implications of switching from CLSI to BrCAST/EUCAST guidelines.

Authors:  Vinícius Pietta Perez; Jéssica Karoliny Baptista Porto Carvalho; Marianne Schrader de Oliveira; Adriana Medianeira Rossato; Caroline Dani; Gertrudes Corção; Pedro Alves d'Azevedo
Journal:  Braz J Microbiol       Date:  2020-04-23       Impact factor: 2.476

6.  Using MALDI-TOF MS typing method to decipher outbreak: the case of Staphylococcus saprophyticus causing urinary tract infections (UTIs) in Marseille, France.

Authors:  K D Mlaga; G Dubourg; C Abat; H Chaudet; L Lotte; S M Diene; D Raoult; R Ruimy; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-22       Impact factor: 3.267

7.  In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.

Authors:  Tarani Kanta Barman; Manoj Kumar; Tarun Mathur; Tridib Chaira; G Ramkumar; Vandana Kalia; Madhvi Rao; Manisha Pandya; Ajay Singh Yadav; Biswajit Das; Dilip J Upadhyay; Rituraj Konwar; V Samuel Raj; Harpal Singh
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

8.  Characterization of ocular methicillin-resistant Staphylococcus epidermidis isolates belonging predominantly to clonal complex 2 subcluster II.

Authors:  Paulo J M Bispo; Ana Luisa Hofling-Lima; Antonio C C Pignatari
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

9.  Comparative epidemiology of Staphylococcus epidermidis isolates from patients with catheter-related bacteremia and from healthy volunteers.

Authors:  S Cherifi; B Byl; A Deplano; C Nonhoff; O Denis; M Hallin
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

10.  Hemoculture and Direct Sputum Detection of mecA-Mediated Methicillin-Resistant Staphylococcus aureus by Loop-Mediated Isothermal Amplification in Combination With a Lateral-Flow Dipstick.

Authors:  Kawin Nawattanapaiboon; Photchanathorn Prombun; Pitak Santanirand; Apirom Vongsakulyanon; Toemsak Srikhirin; Boonsong Sutapun; Wansika Kiatpathomchai
Journal:  J Clin Lab Anal       Date:  2016-03-17       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.